125 related articles for article (PubMed ID: 4052224)
1. Comparison of cytologic and acridine-orange flow-cytometric detection of malignant cells in human body cavity fluids.
Katz RL; Johnson TS; Williamson KD
Anal Quant Cytol Histol; 1985 Sep; 7(3):227-35. PubMed ID: 4052224
[TBL] [Abstract][Full Text] [Related]
2. Flow immunocytochemistry of marker expression in cells from body cavity fluids.
Krishan A; Ganjei-Azar P; Hamelik R; Sharma D; Reis I; Nadji M
Cytometry A; 2010 Feb; 77(2):132-43. PubMed ID: 19899128
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic value of DNA analysis in effusions by flow cytometry and image analysis. A prospective study on 102 patients as compared with cytologic examination.
Rijken A; Dekker A; Taylor S; Hoffman P; Blank M; Krause JR
Am J Clin Pathol; 1991 Jan; 95(1):6-12. PubMed ID: 1987753
[TBL] [Abstract][Full Text] [Related]
4. Role of DNA flow cytometry and image cytometry on effusion fluid.
Saha I; Dey P; Vhora H; Nijhawan R
Diagn Cytopathol; 2000 Feb; 22(2):81-5. PubMed ID: 10649516
[TBL] [Abstract][Full Text] [Related]
5. DNA flow cytometry of pleural effusions. Comparison with pathology for the diagnosis of malignancy.
Evans DA; Thornthwaite JT; Ng AB; Sugarbaker EV
Anal Quant Cytol; 1983 Mar; 5(1):19-27. PubMed ID: 6846965
[TBL] [Abstract][Full Text] [Related]
6. Comparison of DNA flow cytometric analysis of body cavity fluids with conventional cytology.
Lima CE; Mizushima Y; Masuda S; Kitagawa M
In Vivo; 1994; 8(3):359-62. PubMed ID: 7803718
[TBL] [Abstract][Full Text] [Related]
7. Flow cytometric DNA analysis of pleural effusions.
Huang MS; Tsai MS; Wang TH; Lin MS; Chong IW; Chen KL; Hwang JJ
Gaoxiong Yi Xue Ke Xue Za Zhi; 1992 Dec; 8(12):640-6. PubMed ID: 1296045
[TBL] [Abstract][Full Text] [Related]
8. Role of DNA flow cytometry and immunocytochemical analysis in diagnosis of malignant effusions.
Kundu R; Handa U; Mohan H
Diagn Cytopathol; 2012 Oct; 40(10):887-92. PubMed ID: 21485027
[TBL] [Abstract][Full Text] [Related]
9. Flow cytometric analysis and cytopathology of body cavity fluids.
Stonesifer KJ; Xiang JH; Wilkinson EJ; Benson NA; Braylan RC
Acta Cytol; 1987; 31(2):125-30. PubMed ID: 3469844
[TBL] [Abstract][Full Text] [Related]
10. Benign and malignant cells in effusions: diagnostic value of image DNA cytometry in comparison to cytological analysis.
Decker D; Stratmann H; Springer W; Schwering H; Varnai N; Bollmann R
Pathol Res Pract; 1998; 194(11):791-5. PubMed ID: 9842638
[TBL] [Abstract][Full Text] [Related]
11. Complementary value of DNA flow cytometry and image morphometry in detection of malignant cells in effusion fluids.
Bisht B; Handa U; Mohan H; Lehl SS
Malays J Pathol; 2014 Aug; 36(2):83-90. PubMed ID: 25194530
[TBL] [Abstract][Full Text] [Related]
12. Acridine-orange flow cytometry of urinary bladder washings for the detection of transitional cell carcinoma of the bladder. The influence of prior local therapy.
Têtu B; Katz RL; Kalter SP; von Eschenbach AC; Barlogie B
Cancer; 1987 Oct; 60(8):1815-22. PubMed ID: 3652008
[TBL] [Abstract][Full Text] [Related]
13. Multiparameter flow cytometric DNA analysis of effusions: a prospective study of 36 cases compared with routine cytology and immunohistochemistry.
Joseph MG; Banerjee D; Harris P; Gibson S; McFadden RG
Mod Pathol; 1995 Aug; 8(6):686-93. PubMed ID: 8532707
[TBL] [Abstract][Full Text] [Related]
14. Image analysis and flow cytometric DNA studies of benign and malignant body cavity fluids: reappraisal of the role of current methods in the differential diagnosis of reactive versus malignant conditions.
Lazcano O; Chen LM; Tsai C; Li CY; Katzmann JA; Sebo TJ; Kimlinger TK; Baker J
Mod Pathol; 2000 Jul; 13(7):788-96. PubMed ID: 10912939
[TBL] [Abstract][Full Text] [Related]
15. Prospective study of concurrent ploidy analysis and routine cytopathology in body cavity fluids.
Sinton EB; Carver RK; Morgan DL; Philpott PJ; Truell JE; Riemann D; Ashton ME
Arch Pathol Lab Med; 1990 Feb; 114(2):188-94. PubMed ID: 2302036
[TBL] [Abstract][Full Text] [Related]
16. Interphase nucleolar organizer regions in the evaluation of serosal cavity effusions.
Carrillo R; Sneige N; el-Naggar AK
Acta Cytol; 1994; 38(3):367-72. PubMed ID: 8191825
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of flow cytometric immunophenotyping and DNA analysis for detection of malignant cells in serosal cavity fluids.
Sayed DM; el-Attar MM; Hussein AA
Diagn Cytopathol; 2009 Jul; 37(7):498-504. PubMed ID: 19217060
[TBL] [Abstract][Full Text] [Related]
18. The role of DNA flow and image cytometry in the evaluation of body cavity fluids.
Kapusta L; Zbieranowski I; Demianiuk C; Murray D
Anal Quant Cytol Histol; 1991 Jun; 13(3):187-92. PubMed ID: 1910419
[TBL] [Abstract][Full Text] [Related]
19. DNA ploidy, S-phase, and Ki-67 antigen expression in the evaluation of cell content of pleural effusions.
Sikora J; Dworacki G; Zeromski J
Lung; 1996; 174(5):303-13. PubMed ID: 8843056
[TBL] [Abstract][Full Text] [Related]
20. Detection of tumor cells in body cavity fluids by flow cytometric and immunocytochemical analysis.
Krishan A; Ganjei-Azar P; Jorda M; Hamelik RM; Reis IM; Nadji M
Diagn Cytopathol; 2006 Aug; 34(8):528-41. PubMed ID: 16850481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
